Kaplan–Meier Survival Analysis in MedCalc: Complete Guide with Interpretation

Introduction

Kaplan–Meier Survival Analysis is one of the most widely used statistical methods in biomedical research to estimate the survival probability of subjects over time. It is particularly useful when dealing with censored data, which commonly occurs in clinical trials where not all subjects experience the event of interest during the study period.

Definition

Kaplan–Meier Survival Analysis is a non-parametric statistical method used to estimate the survival function from time-to-event data.

👉 It calculates the probability that a subject survives beyond a certain time.

Concept Explanation

🔹 Key Concepts:

  • Survival Time: Time until the event occurs (e.g., death, relapse)
  • Event (Status = 1): Occurrence of outcome
  • Censored Data (Status = 0): Subject did not experience event during study
  • Survival Function (S(t)): Probability of surviving past time t
  • Hazard: Risk of event at a specific time

🔹 Kaplan–Meier Formula:

S(t)=(1dini)S(t) = \prod \left(1 – \frac{d_i}{n_i}\right)

Where:

  • did_i = number of events at time i
  • nin_i​ = number at risk at time i

Data Format

Your dataset in MedCalc includes:

VariableDescription
Time_monthsSurvival time
StatusEvent indicator (1 = event, 0 = censored)
TreatmentGroup (Drug A / Drug B)

📥 Download Dataset:

8 KB

Step-by-Step Procedure in MedCalc

Step 1: Open MedCalc

  • Launch MedCalc software

Step 2: Enter Data

  • Input three columns:
    • Time (months)
    • Status (0/1)
    • Treatment group

Step 3: Select Analysis

  • Go to:
    Statistics → Survival Analysis → Kaplan-Meier

Step 4: Assign Variables

  • Survival time → Time_months
  • Event indicator → Status
  • Factor → Treatment

Step 5: Choose Options

  • Confidence Interval (95%)
  • Display survival table
  • Compare groups (Log-rank test)

Step 6: Generate Output

  • Click OK
  • MedCalc produces:
    • Survival curves
    • Summary tables
    • Statistical tests

Step-by-Step Result Explanation

Cases Summary

From your output :

GroupEventsCensoredTotal
Drug A5 (62.5%)38
Drug B4 (57.14%)37

👉 Interpretation:

  • Both groups have similar event proportions
  • Slightly higher events in Drug A

Mean and Median Survival

GroupMean SurvivalMedian Survival
Drug A15.5 months18 months
Drug B13.4 months14 months

👉 Interpretation:

  • Drug A shows higher survival time
  • Median survival is notably better in Drug A

Survival Table

The survival table shows survival probabilities at different times.

Example:

  • At time 5 → Survival ≈ 87.5% (Drug A)
  • At time 14 → Survival drops significantly

👉 Interpretation:

  • Survival decreases stepwise over time
  • Each drop represents an event

Kaplan–Meier Plot Interpretation

Key Features of Your Graph:

  • Step-down curves: Each drop = event occurrence
  • Two groups:
    • Blue line → Drug A
    • Green dashed → Drug B
  • Shaded area: Confidence intervals
  • Number at risk table: Shows subjects remaining over time

Interpretation:

  • Drug A curve stays slightly above Drug B
  • Indicates better survival probability
  • However, curves are close → difference is small

Log-Rank Test (Group Comparison)

From your file:

  • Chi-square = 0.1185
  • p-value = 0.7306

👉 Interpretation:

  • p > 0.05 → Not statistically significant
  • No strong evidence that Drug A is better than Drug B

Hazard Ratio

ComparisonHazard Ratio
Drug A vs Drug B1.2798

👉 Interpretation:

  • HR > 1 suggests slightly higher risk in Drug B
  • But confidence interval is wide → not significant

Conclusion

Kaplan–Meier Survival Analysis is a powerful and essential tool in biostatistics for analyzing time-to-event data. Using MedCalc, researchers can easily generate survival curves, compare treatment groups, and interpret clinical outcomes.

In your analysis:

  • Drug A shows slightly better survival
  • However, statistical tests confirm no significant difference between treatments

Thus, Kaplan–Meier analysis not only provides visual insights but also supports evidence-based conclusions in biomedical research.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top